4
Changes in Ownership
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-14-000009
Chief Scientific Officer sold 531,185 shares at $0.15 ($79,678)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| NIGALAYE ASHOK G Chief Scientific Officer | 2013-01-03 | Sale | −531,185 | $0.15 | $79,678 | 21,161,605 | I: show line 1 in the form |
| Open-market sales · 531,185 sh · avg $0.15 · $79,678 | |||||||
Loading xslF345X03/primary_doc.xml…